Comparison
17 20 Lyase Deficiency Isolated Included CN372394 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 17 20 Lyase Deficiency Isolated Included CN372394 and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
17 20 Lyase Deficiency Isolated Included CN372394
0-16
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
17 20 Lyase Deficiency Isolated Included CN372394
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
17 20 Lyase Deficiency Isolated Included CN372394
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
17-20-lyase-deficiency-isolated-included-CN372394 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 17 20 Lyase Deficiency Isolated Included CN372394 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Pubertal or sex-development concern | May present with atypical genital development or delayed puberty from impaired sex-steroid production; pattern is not uniform. | Developmental features vary and are not specifically defined by sex-steroid deficiency. | Moderate |
| Developmental or congenital features | Primarily an endocrine disorder; broader congenital anomalies are not established by the supplied data. | Described as a congenital chromosomal duplication with varied developmental features. | Moderate |
| Systemic illness pattern | Source classifies it as severe and endocrine, with childhood onset possible. | Source classifies it as moderate, congenital, and genetic, with variable presentation. | Low |
When to favor each condition
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
Suspected disorder of sex development or absent puberty
The endocrine category and steroidogenic mechanism make specialist hormone evaluation relevant.
Moderate
Need to distinguish enzyme deficiency from a copy-number syndrome
Biochemical steroid profiling, interpreted by a clinician, targets the proposed left condition.
Moderate
Family history suggesting a single-gene endocrine disorder
Genetic confirmation may be considered, but inheritance and results require specialist interpretation.
Low
Choose 11p15 4 Microduplication Syndrome C4749508 when
Unexplained developmental differences with possible chromosomal imbalance
The supplied description supports individualized assessment for a rare 11p15.4 duplication.
Moderate
Congenital phenotype without a clear steroidogenic pattern
A chromosomal rather than endocrine-first evaluation may be more appropriate.
Moderate
Prior microarray suggests duplication at 11p15.4
Laboratory confirmation and phenotype correlation should be reviewed by a genetics clinician.
High
How key tests differ
| Test | 17 20 Lyase Deficiency Isolated Included CN372394 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Steroid hormone profile | May show impaired sex-steroid production; exact cutoffs are not established here. | No specific steroid abnormality is established. | An abnormal profile supports endocrine evaluation but is not itself a diagnosis. |
| Chromosomal microarray | Not expected to define isolated lyase deficiency. | May identify duplication involving 11p15.4 when present. | Copy-number findings require clinical correlation and confirmation. |
| Targeted genetic testing | May investigate genes involved in 17,20-lyase function when clinically indicated. | Focuses on chromosomal dosage rather than a single steroidogenic enzyme. | Test choice and interpretation belong to specialist care. |
Prognosis comparison
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- Chronic endocrine condition; outcome varies and no reliable mortality estimate is supplied.
- Factors
- Age at recognition, hormone findings, genetic confirmation, and access to specialist care.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Variable congenital phenotype, described as moderate in the source but individually unpredictable.
- Factors
- Duplication extent, associated genes, developmental findings, and supportive services.
Time frame: Often recognized from infancy through adolescence; lifelong course is possible.
Prognosis cannot be generalized from these sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Sex-hormone deficiency effects | Possible pubertal delay, infertility concerns, or bone-health risk if untreated; occurrence varies. Not established as a characteristic complication. Management and monitoring require individualized endocrine care. |
| Developmental impairment | Not established from the supplied source. Varied developmental features may occur, but severity is not uniform. Early developmental assessment can guide support. |
| Adrenal or cortisol insufficiency | Not automatically present in isolated lyase deficiency and must not be assumed. Not established by the supplied description. Urgent symptoms need clinician assessment rather than self-diagnosis. |
Patient education highlights
- HighDiagnosis is specialist-led
Neither label should be assigned from symptoms alone; genetic or endocrine results need clinical interpretation.
- MediumConditions differ biologically
One concerns steroid hormone production; the other is a chromosomal duplication with variable development.
- LowNot contagious
Neither condition is communicable, and both generally require long-term individualized follow-up.